Filing Flows › Regen BioPharma (RGBP) › Q2 FY26 › vs Q1 FY26
Regen BioPharma (RGBP) Q2 FY26 vs Q1 FY26 (quarter over quarter)
Regen BioPharma's revenue rose $0 (0%) from $59K in Q1 FY26 to $59K in Q2 FY26.
Regen BioPharma, Q2 FY26: revenue $59K (0% year over year), operating margin -260.2%, net earnings $992K, operating cash flow −$63K. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $59K | $59K | $0 | 0% |
| Other income, net | $1.1M | −$416K | $1.6M | — |
| Costs & expenses | $1.2M | $1.0M | $178K | +17% |
| Operating costs | $213K | $611K | −$398K | -65% |
| Net earnings | $992K | −$968K | $2.0M | — |
| Research & development | $2K | $210K | −$208K | -99% |
| General & admin | $32K | $232K | −$200K | -86% |
| Other operating costs | $178K | $169K | $10K | +6% |
| Operating cash sources | $1.1M | −$770K | $1.8M | — |
| Cash used in operations | $63K | $198K | −$135K | -68% |
| Working capital & other | $1.1M | −$770K | $1.8M | — |
Questions
How much did Regen BioPharma's revenue grow quarter over quarter in Q2 FY26?
Regen BioPharma's revenue rose $0 (0%) from $59K in Q1 FY26 to $59K in Q2 FY26.